Literature DB >> 8349561

Generation of restriction map of Enterococcus faecalis OG1 and investigation of growth requirements and regions encoding biosynthetic function.

B E Murray1, K V Singh, R P Ross, J D Heath, G M Dunny, G M Weinstock.   

Abstract

A defined synthetic medium was used to determine the amino acid requirements of Enterococcus faecalis OG1 and to demonstrate the absence of a requirement for exogenous purines or pyrimidines. Genomic libraries prepared from strain OG1 were transduced into Escherichia coli auxotrophic mutants, and cloned DNAs which complemented pyrC, pyrD, purF, purL, and guaAB mutations were identified. These and other cloned DNAs with known functions were localized on a restriction map of OG1 which was generated with SfiI (5 fragments), AscI (9 fragments), and NotI (15 fragments); the size of the OG1 chromosome was revised from a previous estimate of approximately 2,750 kb to 2,825 kb. The synthetic medium and the restriction map should be useful for studying enterococcal metabolic functions and the relationships between chromosomally encoded genes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349561      PMCID: PMC204989          DOI: 10.1128/jb.175.16.5216-5223.1993

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  25 in total

Review 1.  THE GROUP D STREPTOCOCCI.

Authors:  R H DEIBEL
Journal:  Bacteriol Rev       Date:  1964-09

2.  Some factors affecting the nutritional requirements of Streptococcus faecalis.

Authors:  T A MCCOY; S H WENDER
Journal:  J Bacteriol       Date:  1953-06       Impact factor: 3.490

Review 3.  Beta-lactamase-producing enterococci.

Authors:  B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

4.  Mutants of Enterococcus faecalis deficient as recipients in mating with donors carrying pheromone-inducible plasmids.

Authors:  K M Trotter; G M Dunny
Journal:  Plasmid       Date:  1990-07       Impact factor: 3.466

Review 5.  Emergence of Enterococcus as a significant pathogen.

Authors:  R C Moellering
Journal:  Clin Infect Dis       Date:  1992-06       Impact factor: 9.079

6.  Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states.

Authors:  B E Murray; K V Singh; S M Markowitz; H A Lopardo; J E Patterson; M J Zervos; E Rubeglio; G M Eliopoulos; L B Rice; F W Goldstein
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

7.  NotI genomic cleavage map of Escherichia coli K-12 strain MG1655.

Authors:  J D Heath; J D Perkins; B Sharma; G M Weinstock
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

8.  Recombination-deficient mutant of Streptococcus faecalis.

Authors:  Y Yagi; D B Clewell
Journal:  J Bacteriol       Date:  1980-08       Impact factor: 3.490

9.  Cloning, sequence and overexpression of NADH peroxidase from Streptococcus faecalis 10C1. Structural relationship with the flavoprotein disulfide reductases.

Authors:  R P Ross; A Claiborne
Journal:  J Mol Biol       Date:  1991-10-05       Impact factor: 5.469

10.  Major trends in the microbial etiology of nosocomial infection.

Authors:  D R Schaberg; D H Culver; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

View more
  122 in total

1.  Characterization of fsr, a regulator controlling expression of gelatinase and serine protease in Enterococcus faecalis OG1RF.

Authors:  X Qin; K V Singh; G M Weinstock; B E Murray
Journal:  J Bacteriol       Date:  2001-06       Impact factor: 3.490

2.  Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints.

Authors:  Jose M Munita; Diana Panesso; Lorena Diaz; Truc T Tran; Jinnethe Reyes; Audrey Wanger; Barbara E Murray; Cesar A Arias
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

3.  Cardiac Microlesions Form During Severe Bacteremic Enterococcus faecalis Infection.

Authors:  Armand O Brown; Kavindra V Singh; Melissa R Cruz; Karan Gautam Kaval; Liezl E Francisco; Barbara E Murray; Danielle A Garsin
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

4.  Enterococcus faecalis rnjB is required for pilin gene expression and biofilm formation.

Authors:  Peng Gao; Kenneth L Pinkston; Sreedhar R Nallapareddy; Ambro van Hoof; Barbara E Murray; Barrett R Harvey
Journal:  J Bacteriol       Date:  2010-08-20       Impact factor: 3.490

Review 5.  Enterococcus infection biology: lessons from invertebrate host models.

Authors:  Grace J Yuen; Frederick M Ausubel
Journal:  J Microbiol       Date:  2014-03-01       Impact factor: 3.422

6.  Comparison of OG1RF and an isogenic fsrB deletion mutant by transcriptional analysis: the Fsr system of Enterococcus faecalis is more than the activator of gelatinase and serine protease.

Authors:  Agathe Bourgogne; Susan G Hilsenbeck; Gary M Dunny; Barbara E Murray
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

7.  Resistance of Enterococcus faecium to neutrophil-mediated phagocytosis.

Authors:  R C Arduino; K Jacques-Palaz; B E Murray; R M Rakita
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  A cluster of genes involved in polysaccharide biosynthesis from Enterococcus faecalis OG1RF.

Authors:  Y Xu; B E Murray; G M Weinstock
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Molecular characterization of a widespread, pathogenic, and antibiotic resistance-receptive Enterococcus faecalis lineage and dissemination of its putative pathogenicity island.

Authors:  Sreedhar R Nallapareddy; Huang Wenxiang; George M Weinstock; Barbara E Murray
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

10.  Importance of the ebp (endocarditis- and biofilm-associated pilus) locus in the pathogenesis of Enterococcus faecalis ascending urinary tract infection.

Authors:  Kavindra V Singh; Sreedhar R Nallapareddy; Barbara E Murray
Journal:  J Infect Dis       Date:  2007-04-26       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.